Corvus Pharmaceuticals, Inc. Contracts & Agreements

42 Contracts & Agreements
Browse by Contract Category
Contracts
Category
Company
Industry
Jur. Jurisdiction
Filed
Amendment No. 1 to the Phase I/IB Combination Study Agreement, dated December 20, 2017, by and between Corvus Pharmaceuticals, Inc. and Genentech, Inc
Corvus Pharmaceuticals, Inc.
Biotechnology
2020
Sub-Sublease, by and between NewLimit, Inc. and Corvus Pharmaceuticals, Inc., dated as of October 22, 2024
Corvus Pharmaceuticals, Inc.
2024
Employment Agreement, dated as of February 2, 2024 by and between Corvus Pharmaceuticals, Inc. and Jeffrey S. Arcara
Employment Agreements
Corvus Pharmaceuticals, Inc.
2024
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Corvus Pharmaceuticals, Inc.
2024
Form of Pre-Funded Warrant
Warrant Agreements
Corvus Pharmaceuticals, Inc.
2024
Form of Common Warrant
Warrant Agreements
Corvus Pharmaceuticals, Inc.
2024
Securities Purchase Agreement, dated May 1, 2024, between the Company and the Investors
Purchase Agreements
Corvus Pharmaceuticals, Inc.
2024
Amendment No. 1 to Sales Agreement, dated as of May 1, 2024, between Corvus Pharmaceutical, Inc. and Jefferies LLC
Sales Agreements
Corvus Pharmaceuticals, Inc.
2024
Amendment to Amended and Restated Employment Agreement, dated as of March 31, 2023, by and between Corvus Pharmaceuticals, Inc. and Richard A. Miller
Employment Agreements
Corvus Pharmaceuticals, Inc.
2023
Open Market Sale Agreement, dated November 1, 2021, by and between Corvus Pharmaceuticals, Inc. and Jefferies LLC
Corvus Pharmaceuticals, Inc.
Biotechnology
NY
2022
Sales Agreement, dated as of November 1, 2021, between Corvus Pharmaceuticals, Inc. and Jefferies LLC
Sales Agreements
Corvus Pharmaceuticals, Inc.
2021
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Corvus Pharmaceuticals, Inc.
2021
Underwriting Agreement, dated as of February 12, 2021, among Corvus Pharmaceuticals, Inc. and Cantor Fitzgerald & Co. and H.C. Wainwright & Co., LLC as the underwriters
Underwriting Agreements
Corvus Pharmaceuticals, Inc.
2021
Phase I/IB Combination Study Agreement, dated October 5, 2015, by and between Corvus Pharmaceuticals, Inc. and Genentech, Inc
Corvus Pharmaceuticals, Inc.
Biotechnology
DE
2020
Framework Agreement, dated October 5, 2020, by and among Corvus Hong Kong Limited, Angel Pharmaceutical Co., Ltd., Jiaxng Puissance Angel Equity Investment Partnership (Limited...
Development Agreements
Corvus Pharmaceuticals, Inc.
2020
Transition and Consulting Agreement, dated June 30, 2020 by and between Corvus Pharmaceuticals, Inc. and Joseph Buggy
Consulting Agreements
Corvus Pharmaceuticals, Inc.
Biotechnology
CA
2020
Amendment No. 1 to the Phase 1b/II Combination Study Agreement dated December 20, 2017, by and between Corvus Pharmaceuticals, Inc. and Genentech, Inc
Corvus Pharmaceuticals, Inc.
2020
Exclusive License Agreement dated April 21, 2017, by and between Corvus Pharmaceuticals, Inc. and Monash University
License Agreements
Corvus Pharmaceuticals, Inc.
2020
Amendment No. 2 to the Phase I/IB Combination Study Agreement, dated August 1, 2019, by and between Corvus Pharmaceuticals, Inc. and Genentech, Inc
Corvus Pharmaceuticals, Inc.
2020
Description of Registrants Securities Registered Pursuant to Section 12 of the Securities Exchange Act of 1934
Corvus Pharmaceuticals, Inc.
Biotechnology
2020
Exchange Agreement, dated November 8, 2019, by and among, Corvus Pharmaceuticals, Inc., Biotechnology Value Fund, L.P., Biotechnology Value Fund II, L.P. and Biotechnology Value...
Exchange Agreements
Corvus Pharmaceuticals, Inc.
Biotechnology
NY
2019
Form of Warrant
Warrant Agreements
Corvus Pharmaceuticals, Inc.
2019
Offer Letter, dated as of January 7, 2019 by and between Corvus Pharmaceuticals, Inc. and Mehrdad Mobasher
Corvus Pharmaceuticals, Inc.
2019
Seventh Amendment to Office Lease, dated as of October 11, 2018, by and between Corvus Pharmaceuticals, Inc. and ARE819/863 Mitten Road, LLC
Lease Agreements
Corvus Pharmaceuticals, Inc.
Biotechnology
2019
Change in Control and Severance Agreement, dated January 28, 2019, by and between Corvus Pharmaceuticals, Inc. and Mehrdad Mobasher
Change of Control Agreements
Corvus Pharmaceuticals, Inc.
2019
Sixth Amendment to Office Lease dated as of April 5, 2018, by and between , Corvus Pharmaeuticals, Inc. and ARE-819/863 Mitten Road, LLC
Lease Agreements
Corvus Pharmaceuticals, Inc.
2018
Employment Agreement, dated November 26, 2014, by and between the Company and Joseph J. Buggy
Employment Agreements
Corvus Pharmaceuticals, Inc.
2018
Fifth Amendment to Office Lease dated as of March 2, 2018, by and between , Corvus Pharmaeuticals, Inc. and ARE-819/863 Mitten Road, LLC
Lease Agreements
Corvus Pharmaceuticals, Inc.
Biotechnology
2018
Underwriting Agreement, dated as of March 8, 2018, among Corvus Pharmaceuticals, Inc. and Credit Suisse Securities (USA) LLC and Jefferies LLC, as representatives of the...
Underwriting Agreements
Corvus Pharmaceuticals, Inc.
Biotechnology
NY
2018
Offer Letter, dated as of November 22, 2017 by and between Corvus Pharmaceuticals, Inc. and Daniel Hunt
Corvus Pharmaceuticals, Inc.
2018
Change in Control and Severance Agreement dated December 13, 2017, by and between Corvus Pharmaceuticals, Inc. and Daniel Hunt
Change of Control Agreements
Corvus Pharmaceuticals, Inc.
2018
Sales Agreement, dated as of September 20, 2017, between Corvus Pharmaceuticals, Inc. and Cowen and Company, LLC
Sales Agreements
Corvus Pharmaceuticals, Inc.
2017
[***] Certain information in this document has been omitted and filed separately with the Securities and Exchange Commission. Confidential treatment has been requested with...
Corvus Pharmaceuticals, Inc.
Biotechnology
DE
2017
FOURTH AMENDMENT TO LEASE
Lease Agreements
Corvus Pharmaceuticals, Inc.
Biotechnology
2016
CORVUS PHARMACEUTICALS, INC. CHANGE IN CONTROL SEVERANCE AGREEMENT
Change of Control Agreements
Corvus Pharmaceuticals, Inc.
Biotechnology
CA
2016
THIRD AMENDMENT TO LEASE
Lease Agreements
Corvus Pharmaceuticals, Inc.
2016
LICENSE AGREEMENT Dated February 25, 2015 (1) Vernalis (R&D) Limited (2) Corvus Pharmaceuticals, Inc.
License Agreements
Corvus Pharmaceuticals, Inc.
Biotechnology
CA
2016
PHASE I/IB COMBINATION STUDY AGREEMENT BY AND BETWEEN GENENTECH, INC. AND CORVUS PHARMACEUTICALS, INC.
Corvus Pharmaceuticals, Inc.
Biotechnology
DE
2016
LICENSE AGREEMENT Dated February 25, 2015 (1) Vernalis (R&D) Limited (2) Corvus Pharmaceuticals, Inc.
License Agreements
Corvus Pharmaceuticals, Inc.
2016
CORVUS PHARMACEUTICALS, INC. 2016 EQUITY INCENTIVE AWARD PLAN ARTICLE 1. PURPOSE
Bonus & Incentive Agreements
Corvus Pharmaceuticals, Inc.
2016
CORVUS PHARMACEUTICALS, INC. AMENDED AND RESTATED INVESTORS RIGHTS AGREEMENT
Investor Rights Agreements
Corvus Pharmaceuticals, Inc.
Biotechnology
CA
2016
Corvus Pharmaceuticals, Inc. UNDERWRITING AGREEMENT
Underwriting Agreements
Corvus Pharmaceuticals, Inc.
2016